Telcare, a US-based provider of monitors that let people know their blood-sugar levels, has raised $25.5m in its series B round from a consortium including chip maker Qualcomm’s $100m Life corporate venturing fund.
Venture capital firm Sequoia Capital led the B round, which followed a $4.5m A round from a consortium also including Qualcomm at the end of last year. Telcare was founded in 2008.
Jack Young, director of Qualcomm Ventures and head if the Kife Fund, said: “Telcare’s solution…
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
